To test if treatment with metformin reduces obesity-induced IR, we evaluated the blood glucose levels before and at 5 to 30 min after administration of recombinant human insulin (1 IU/kg), and calculated the constant rate for glucose disappearance (KITT). The gene discussed is INS; the disease is obesity disorder.